Copyright
©2012 Baishideng.
World J Gastrointest Pharmacol Ther. Apr 6, 2012; 3(2): 21-28
Published online Apr 6, 2012. doi: 10.4292/wjgpt.v3.i2.21
Published online Apr 6, 2012. doi: 10.4292/wjgpt.v3.i2.21
Table 2 Liver ultrasound: information for the management of liver diseases
| Parenchymal signs | |
| Dimensions | Hepatomegaly |
| Caudate lobe hypertrophy | |
| Quadrate lobe hypotrophy | |
| Echo pattern | Coarse: typical of liver fibrosis |
| Coarse nodular: micronodular cirrhosis | |
| Attenuation sign/bright liver: typical of hepatic steatosis | |
| Nodules | Benign vs malignant lesions |
| Skip areas (fatty liver) | |
| Surface | Nodular vs smooth |
| Extraparenchymal signs | |
| Indirect signs of portal hypertension | Splenomegaly |
| Ascites | |
| Collateral vessels | |
| Lack of splenic and/or superior mesenteric vein diameter variations during breathing | |
| Increased portal vein diameter | |
| Doppler ultrasound | Inversion/reduction of portal vein flow |
| Portal vein thrombosis/cavernomatosis |
- Citation: Marignani M, Fonzo MD, Begini P, Gigante E, Deli I, Pellicelli AM, Gallina S, Santis E, Fave GD, Cox MC. ‘Les liaisons dangereuses’: Hepatitis C, Rituximab and B-cell non-Hodgkin’s lymphomas. World J Gastrointest Pharmacol Ther 2012; 3(2): 21-28
- URL: https://www.wjgnet.com/2150-5349/full/v3/i2/21.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v3.i2.21